Deignan Charles A.
- SEC CIK
- 0001664690
No open-market purchases or sales filed in the past year.
Current role at each company
- CLSD Clearside Biomedical, Inc.Chief Financial Officeras of Jan 10, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Deignan Charles A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 (view filing) | Jan 19 | Same day | Deignan Charles A.Chief Financial Officer | SSale | −12.9K | $1.28 | −$16.5K | −3.2%384.7K after | |
| Jan 20, 2023 (view filing) | Jan 19 | 1 day | Deignan Charles A.Chief Financial Officer | SSale | −14.0K | $1.50 | −$21.0K | −3.7%363.5K after | |
| Jan 20, 2022 (view filing) | Jan 19 | 1 day | Deignan Charles A.Chief Financial Officer | SSale | −8.83K | $2.09 | −$18.5K | −2.5%351.4K after | From original |
| Sep 23, 2021 (view filing) | Sep 21 | 2 days | Deignan Charles A.Chief Financial Officer | SSale | −2.80K | $6.41 | −$17.9K | −0.9%316.4K after |